Management and outcomes of adolescent and young adult sarcoma patients: results from the French nationwide database NETSARC

Archive ouverte

Kubicek, Pierre | Cesne, Axel Le | Lervat, Cyril | Toulmonde, Maud | Chevreau, Christine | Duffaud, Florence | Le Nail, Louis-Romée | Morelle, Magali | Gaspar, Nathalie | Vérité, Cécile | Castex, Marie-Pierre | Penel, Nicolas | Saada, Esma | Causeret, Sylvain | Bertucci, François | Perrin, Christophe | Bompas, Emmanuelle | Orbach, Daniel | Laurence, Valérie | Piperno-Neumann, Sophie | Anract, Philippe | Rios, Maria | Gentet, Jean-Claude | Mascard, Éric | Pannier, Stéphanie | Blouin, Pascale | Carrère, Sébastien | Chaigneau, Loïc | Soibinet-Oudot, Pauline | Corradini, Nadège | Boudou-Rouquette, Pascaline | Ruzic, Jean-Christophe | Lebrun-Ly, Valérie | Dubray-Longeras, Pascale | Varatharajah, Sharmini | Lebbe, Céleste | Ropars, Mickaël | Kurtz, Jean-Emmanuel | Guillemet, Cécile | Lotz, Jean-Pierre | Berchoud, Juliane | Cherrier, Grégory | Ducimetière, Françoise | Chemin, Claire | Italiano, Antoine | Honoré, Charles | Desandes, Emmanuel | Blay, Jean-Yves | Gouin, François | Marec-Bérard, Perrine

Edité par CCSD ; BioMed Central -

International audience. Abstract Background The initial management of patients with sarcoma is a critical issue. We used the nationwide French National Cancer Institute -funded prospective sarcoma database NETSARC to report the management and oncologic outcomes in adolescents and young adults (AYAs) patients with sarcoma at the national level. Patients and methods NETSARC database gathers regularly monitored and updated data from patients with sarcoma. NETSARC was queried for patients (15–30 years) with sarcoma diagnosed from 2010 to 2017 for whom tumor resection had been performed. We reported management, locoregional recurrence-free survival (LRFS), progression-free survival (PFS), and overall survival (OS) in AYA treated in French reference sarcoma centers (RSC) and outside RSC (non-RSC) and conducted multivariable survival analyses adjusted for classical prognostic factors. Results Among 3,227 patients aged 15–30 years with sarcoma diagnosed between 2010 and 2017, the study included 2,227 patients with surgery data available, among whom 1,290 AYAs had been operated in RSC, and 937 AYAs in non-RSC. Significant differences in compliance to guidelines were observed including pre-treatment biopsy (RSC: 85.9%; non-RSC 48.1%), pre-treatment imaging (RSC: 86.8%; non-RSC: 56.5%) and R0 margins (RSC 57.6%; non-RSC: 20.2%) ( p < 0.001). 3y-OS rates were 81.1% (95%CI 78.3–83.6) in AYA in RSC and 82.7% (95%CI 79.4–85.5) in AYA in non-RSC, respectively. Whereas no significant differences in OS was observed in AYAs treated in RSC and in non-RSC, LRFS and PFS were improved in AYAs treated in RSC compared to AYAs treated in non-RSC (Hazard Ratios (HR): 0.58 and 0.83, respectively). Conclusions This study highlights the importance for AYA patients with sarcoma to be managed in national sarcoma reference centers involving multidisciplinary medical teams with paediatric and adult oncologists.

Consulter en ligne

Suggestions

Du même auteur

Determinants of the access to remote specialised services provided by national sarcoma reference centres

Archive ouverte | Fayet, Yohan | CCSD

International audience. Background: Spatial inequalities in cancer management have been evidenced by studies reporting lower quality of care or/and lower survival for patients living in remote or socially deprived a...

No Geographical Inequalities in Survival for Sarcoma Patients in France: A Reference Networks' Outcome?

Archive ouverte | Fayet, Yohan | CCSD

International audience. Simple Summary As patients with rare cancers face specific problems, reference networks have been developed in several European countries and then at the European level to improve their manag...

Sarcomas in patients over 90: Natural history and treatment—A nationwide study over 6 years

Archive ouverte | Basse, Clémence | CCSD

International audience. Soft tissue sarcomas (STS) are rare tumors accounting for less than 1% of human cancers. While the highest incidence of sarcomas is observed in elderly, this population is often excluded or p...

Chargement des enrichissements...